• Federal Affairs home

• Comments of the National Mental Health Association on the Draft Model Guidelines for the Medicare Prescription Drug Benefit Developed by the U.S. Pharmacopeia Expert Committee (pdf)

• Comments on Draft Guidelines on Formulary Review for the Medicare Prescription Drug Benefit (pdf)

• Comments on the Centers for Medicare and Medicaid Services’ Notice of Proposed Rulemaking regarding the Medicare Prescription Drug Benefit (pdf)

• Testimony of Cynthia Wainscott for the National Mental Health Association before the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee and Pediatric Advisory Committee September 13, 2004

• Testimony of Michael Faenza, National Mental Health Association CEO, before the President's New Freedom Commission on Mental Health on the Need for Culturally Competent Mental Health Services - August 8, 2002 (pdf)

For more information about the Office of Government Affairs, please call:

Phone: 703/684-7722
Fax: 703/684-5968
Email: fedgovinfo@nmha.org